

KKR vs CME Group
Major global investment manager for private equity and credit vs Global futures and options exchange operator with clearing services. Which is the better buy for your portfolio in June 2026? Plain-English answer below.
KKR is one of the world's premier alternative asset managers raising and deploying capital across private equity, credit, and real assets at global scale, while CME Group operates the world's largest derivatives exchange and earns fees on every futures and options contract traded. Both firms benefit from financial market complexity and the growing institutional need to manage risk or access alternative returns. The KKR vs CME Group comparison contrasts performance-driven asset management economics with the near-utility-like fee stability of exchange infrastructure.
KKR is one of the world's premier alternative asset managers raising and deploying capital across private equity, credit, and real assets at global scale, while CME Group operates the world's largest ...
Why It’s Moving

KKR’s bullish setup is being driven by analyst confidence in stronger deployment, exits, and fee growth.
- Analysts remain broadly constructive on KKR, with consensus ratings clustering around Buy to Strong Buy, which signals continued confidence in the firm’s private-markets franchise and long-term cash-generation model.
- The upside case is tied to a pickup in deployment and exit activity, since more transactions can expand management fees and carried-interest potential while improving sentiment around future earnings.
- The stock is also benefiting from a larger sector tailwind: alternatives managers are being viewed as relatively resilient in a market where investors continue to seek diversified exposure beyond traditional banks and public markets.

CME slides as analysts focus on volatility risks and a tougher near-term setup
- Erste Group cut its view to hold, pointing to volatility concerns that could limit near-term upside for CME’s derivatives-heavy business.
- KBW said fears around perpetual futures look overblown, but the debate itself underscores how sensitive CME’s earnings outlook is to changes in trading volatility and market structure.
- Broader analyst sentiment remains mixed, with some models still flagging modest downside risk even as others see CME as a defensive play when markets get choppy.

KKR’s bullish setup is being driven by analyst confidence in stronger deployment, exits, and fee growth.
- Analysts remain broadly constructive on KKR, with consensus ratings clustering around Buy to Strong Buy, which signals continued confidence in the firm’s private-markets franchise and long-term cash-generation model.
- The upside case is tied to a pickup in deployment and exit activity, since more transactions can expand management fees and carried-interest potential while improving sentiment around future earnings.
- The stock is also benefiting from a larger sector tailwind: alternatives managers are being viewed as relatively resilient in a market where investors continue to seek diversified exposure beyond traditional banks and public markets.

CME slides as analysts focus on volatility risks and a tougher near-term setup
- Erste Group cut its view to hold, pointing to volatility concerns that could limit near-term upside for CME’s derivatives-heavy business.
- KBW said fears around perpetual futures look overblown, but the debate itself underscores how sensitive CME’s earnings outlook is to changes in trading volatility and market structure.
- Broader analyst sentiment remains mixed, with some models still flagging modest downside risk even as others see CME as a defensive play when markets get choppy.
Investment Analysis

KKR
KKR
Pros
- KKR reported strong Q3 2025 earnings, exceeding both EPS and revenue forecasts with robust growth in fee-related earnings.
- The firm achieved record fundraising and expanded its presence in high-growth areas such as private credit and Asian markets.
- KKR's acquisition of OSTTRA enhances its infrastructure and technology offerings, broadening its alternative asset management platform.
Considerations
- Despite strong results, KKR's stock has shown volatility and underperformed in pre-market trading, reflecting investor caution.
- The company trades at a high valuation multiple, which may limit upside and increase sensitivity to market sentiment.
- KKR's earnings are closely tied to fundraising cycles and capital markets activity, making them vulnerable to economic downturns.

CME Group
CME
Pros
- CME Group maintains a dominant position in global derivatives trading, benefiting from high trading volumes and market resilience.
- The company generates stable, recurring revenue from clearing and exchange fees, supporting strong cash flow generation.
- CME Group has a robust balance sheet and a history of returning capital to shareholders through dividends and buybacks.
Considerations
- CME Group's growth is limited by market saturation and regulatory scrutiny in the exchange sector.
- Revenue is sensitive to interest rate changes and macroeconomic conditions, which can impact trading activity.
- The company faces increasing competition from alternative trading platforms and fintech disruptors.
KKR (KKR) Next Earnings Date
KKR’s next earnings date is currently expected around July 30, 2026, with some calendars showing a range of July 29–31, 2026. The report will cover Q2 2026. KKR has not officially confirmed the date yet, so this should be treated as an estimate based on its historical reporting pattern.
CME Group (CME) Next Earnings Date
The next earnings date for CME Group is expected on July 22, 2026, before the market opens. This report will cover Q2 2026 results. CME has not officially confirmed the date yet, but the July timing matches its typical quarterly reporting pattern.
KKR (KKR) Next Earnings Date
KKR’s next earnings date is currently expected around July 30, 2026, with some calendars showing a range of July 29–31, 2026. The report will cover Q2 2026. KKR has not officially confirmed the date yet, so this should be treated as an estimate based on its historical reporting pattern.
CME Group (CME) Next Earnings Date
The next earnings date for CME Group is expected on July 22, 2026, before the market opens. This report will cover Q2 2026 results. CME has not officially confirmed the date yet, but the July timing matches its typical quarterly reporting pattern.
Buy KKR or CME in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


